HK Stock MarketDetailed Quotes

06622 ZHAOKE OPHTH-B

Watchlist
  • 1.350
  • +0.010+0.75%
Market Closed Nov 29 16:08 CST
737.29MMarket Cap-2960P/E (TTM)

About ZHAOKE OPHTH-B Company

Zhaoke Ophthalmology is a leading ophthalmic pharmaceutical company dedicated to the research, development, production and commercialization of treatments to meet the huge gap in medical demand. We have made significant strides in developing an innovative portfolio of assets, reaching our full potential in many major markets around the world. We also have an excellent generic product portfolio and are already generating revenue. Our innovative medicines and generic products jointly target major diseases affecting the anterior and posterior eye joints. The global eye care market is showing huge potential for development, and although Greater China remains our main regional market, we have begun to strategically expand our reach to other selected markets. Our priority is to provide quality ophthalmic medicines to meet the needs gaps of patients and ophthalmologists. We are also committed to promoting innovation in commercialization models. We affirm our social responsibility in all of our activities and work to raise public awareness about eye diseases and eye disease testing and treatment solutions. The overall goal of Zhaoke Ophthalmology is to reduce pain caused by preventable eye diseases, improve the quality of life of ophthalmology patients, and make significant contributions to the vision health of millions of patients around the world.

Company Profile

Symbol06622
Company NameZHAOKE OPHTH-B
ISINKYG989M51017
Listing DateApr 29, 2021
Issue Price16.80
Shares Offered123.57M share(s)
FoundedJan 20, 2017
Registered AddressCayman Islands
Chairmanxiaoyi li
Secretaryshuxin qiu
Audit InstitutionKPMG
Company CategoryOther
Registered OfficeWalkers Corporate Limited 190 Elgin Avenue George Town Grand Cayman KY1-9008 Cayman Islands
Head Office and Principal Place of BusinessRoom 716, 7th Floor, Block 12W, Phase 3, Hong Kong Science Park, Shatin, Hong Kong
Fiscal Year Ends12-31
Employees297
MarketHong Kong motherboard
Phone(020)39062828;(852)23145100
Emailinfo@zkoph.com
Business Zhaoke Ophthalmology Co., Ltd. is a Chinese investment holding company mainly engaged in the development, manufacture and marketing of ophthalmic drugs. The company's products include innovative drugs and generic drugs. The company's products are mainly used in five ophthalmic indications, including dry eye (DED), wet age-related macular degeneration (WAMD), diabetic macular edema (DME), myopia, and glaucoma.

Company Executives

  • Name
  • Position
  • Salary
  • xiaoyi li
  • Chairman of the Board, CEO, Executive Director, Chairman of the Nomination Committee, Chairman of the Executive Committee, Authorized Representative
  • --
  • xiangrong dai
  • Executive Director, Executive Committee Members
  • --
  • yeni li
  • Non-executive Directors
  • --
  • tiantian zhang
  • Non-executive Directors, Remuneration Committee Members, Audit Committee Members
  • --
  • huaijing liu
  • Independent Non-Executive Director, Audit Committee Members
  • 422.00K
  • xianrong huang
  • Independent Non-Executive Director, Chairman of the Audit Committee, Remuneration Committee Members, Nomination Committee Members
  • --
  • yulin lu
  • Independent Non-Executive Director, Remuneration Committee Chairman, Nomination Committee Members
  • --
  • liekui liu
  • President, Chief Scientific Officer
  • --
  • guohui zhang
  • Deputy General Manager
  • --
  • su jiang
  • Director of Clinical Operations
  • --
  • jian ma
  • Senior Quality Control Manager
  • --
  • xinyan feng
  • Chief Financial Officer
  • --
  • Mauro Bove
  • Director of Business Development
  • --
  • jiang feng
  • Director of Marketing and Marketing
  • --
  • liu liu
  • Head of Regulatory Affairs
  • --
  • lei yang
  • General Counsel
  • --
  • shuxin qiu
  • Chief Financial Officer, Authorized Representative, Company Secretary
  • --
  • Samir Chandrakant Patel
  • Strategy Adviser
  • --
  • jianming cai
  • Chief Medical Officer
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data